Recently Diagnosed or Relapsed? Stop Looking For a Miracle Cure, and Use Evidence-Based Therapies To Enhance Your Treatment and Prolong Your Remission
Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
- You are here:
- Home »
- Blog »
- Multiple Myeloma »
- Myeloma Heart Health Omega-3s
Myeloma Heart Health Omega-3s
Myeloma heart health and Omega-3 fatty acids? Why? If you’ve undergone any of the known cardiotoxic regimens to manage your incurable blood cancer, I encourage you to read the study linked below and consider omega-3 fatty acid supplementation.
I posted the video below to explain myeloma heart health and omega-3 fatty acids. The video, however, goes into additional health benefits of omega-3 fatty acids.
The 5 Effects of Omega-3 | Head, Heart, and Beyond!
Keep in mind that I’m talking about taking care of the MM survivor’s mind and body long after they undergo conventional therapies like their induction therapy, their ASCT, etc. My experience is that while conventional therapies may be needed to manage your MM, they can also damage your body.
I am a MM survivor and MM cancer coach. Email me at David.PeopleBeatingCancer@gmail.com to learn more about both conventional and non-conventional therapies to manage your MM.
Good luck,
David Emerson
- MM Survivor
- MM Cancer Coach
- Director PeopleBeatingCancer
Effects of omega-3 fatty acid on major cardiovascular outcomes: A systematic review and meta-analysis
Background:
The effects of omega-3 fatty acid on cardiovascular health obtained inconsistent results. A systematic review and meta-analysis were therefore conducted to assess the effects of omega-3 fatty acid supplementation for primary and secondary prevention strategies of major cardiovascular outcomes.
Methods:
The databases of PubMed, Embase, and the Cochrane library were systematically searched from their inception until September 2020. Relative risks (RRs) with 95% confidence intervals were used to assess effect estimates by using the random-effects model.
Results:
Twenty-eight randomized controlled trials involving 136,965 individuals were selected for the final meta-analysis. Omega-3 fatty acid was noted to be associated with a lower risk of major cardiovascular events (RR, 0.94; 95% CI, 0.89–1.00; P = .049) and cardiac death (RR, 0.92; 95% CI, 0.85–0.99; P = .022). However, no significant differences was noted between omega-3 fatty acid and the control for the risks of all-cause mortality (RR, 0.97; 95% CI, 0.92–1.03; P = .301), myocardial infarction (RR, 0.90; 95% CI, 0.80–1.01; P = .077), and stroke (RR, 1.02; 95% CI, 0.94–1.11; P = .694).
Conclusions:
Major cardiovascular events and cardiac death risks could be avoided with the use of omega-3 fatty acid. However, it has no significant effects on the risk of all-cause mortality, myocardial infarction, and stroke…
Major cardiovascular events
Twenty-two RCTs showed the effect of omega-3 fatty acids on the risk of MACEs. Omega-3 fatty acids was associated with a reduced risk of MACEs (RR, 0.94; 95% CI, 0.89–1.00; P = .049; Fig. 2). In addition, significant heterogeneity was seen across included trials (I2 = 62.0%; P < 0.001). The pooled conclusion for MACEs was variable after sequentially excluding individual trials because of the marginal 95% CI (Supplemental Digital Content 1, http://links.lww.com/MD2/B85). Subgroup analysis suggested that the beneficial effect of omega-3 fatty acids on MACEs risk was mainly observed in the groups with a sample size of ≥1,000, a male proportion of ≥80.0%, omega-3 fatty acids used as primary prevention, follow-up duration of ≥3 years, and trials of high quality (Table 2)…
Cardiac death
Nineteen RCTs showed the effect of omega-3 fatty acids on the risk of cardiac death. The pooled RR indicated that omega-3 fatty acids could protect against cardiac death risk..
In conclusion,
this study found that the use of omega-3 fatty acids could significantly reduce the risk of MACEs and cardiac death. However, no significant differences were found between omega-3 fatty acids and control for the risk of all-cause mortality, MI, and stroke. Further large-scale RCT should be conducted to assess the effects of omega-3 fatty acids on major cardiovascular outcomes. In addition, a cumulative meta-analysis should be conducted to assess the pooled effect estimates in clinical practice.
Myeloma heart health and Omega-3 Myeloma heart health and Omega-3 Myeloma heart health and Omega-3